|
|
Volumn 69, Issue 1, 2008, Pages 6-7
|
|
Opinion on Millar et al., 'Are meticillin-resistant Staphylococcus aureus bloodstream infection targets fair to those with other types of healthcare-associated infection or cost-effective?'
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
EXTENDED SPECTRUM BETA LACTAMASE;
METICILLIN;
POLYPEPTIDE ANTIBIOTIC AGENT;
ACINETOBACTER;
ANTIBIOTIC RESISTANCE;
ARTICLE;
ASEPSIS;
CLINICAL PRACTICE;
CLINICAL PROTOCOL;
COST EFFECTIVENESS ANALYSIS;
ENTEROCOCCUS;
ESCHERICHIA COLI;
HEALTH CARE DELIVERY;
HEALTH CARE PLANNING;
HEALTH PROGRAM;
HOSPITAL HYGIENE;
HOSPITAL INFECTION;
HUMAN;
INFECTION CONTROL;
INFECTION PREVENTION;
MEDICAL INSTRUMENTATION;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
NATIONAL HEALTH SERVICE;
PRESCRIPTION;
STAPHYLOCOCCUS INFECTION;
UNITED KINGDOM;
|
|
EID: 42649126680
PISSN: 01956701
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jhin.2008.02.018 Document Type: Note |
|
Times cited : (3)
|
|
References (1)
|
